|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000197614 |
Summary for MFAP5 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000197614 | Gene symbol | MFAP5 |
| Gene name | microfibril associated protein 5 | |
| HGNC | 29673 | |
| Entrez ID | 8076 | |
| Gene type | protein_coding | |
| Synonyms | MFAP5|MAGP2|MP25 | |
| UniProtAcc | Q13361 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for MFAP5 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| MFAP5 | 7.19e+02 | -3.26e+00 | 8.06e-01 | -4.04e+00 | 5.36e-05 | 2.58e-04 | BLCA |
| MFAP5 | 1.28e+03 | -2.03e+00 | 7.22e-01 | -2.81e+00 | 4.89e-03 | 2.17e-02 | ESCA |
| Differentially expressed gene analysis between tumor female and normal female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| MFAP5 | 3.95e+02 | -1.03e+00 | 3.47e-01 | -2.96e+00 | 3.04e-03 | 5.69e-03 | THCA |
| MFAP5 | 1.58e+03 | 1.32e+00 | 4.92e-01 | 2.68e+00 | 7.34e-03 | 2.24e-02 | HNSC |
| MFAP5 | 3.70e+03 | -1.96e+00 | 1.36e-01 | -1.44e+01 | 6.37e-47 | 5.84e-46 | BRCA |
| MFAP5 | 5.59e+02 | -3.52e+00 | 6.68e-01 | -5.26e+00 | 1.41e-07 | 1.58e-06 | READ |
Top |
Sex-biased somatic mutation for MFAP5 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for MFAP5 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| LUSC | cg15815843 | chr12:8662712 | CGI:chr12:8697456-8698807 | UTR,promoter,exon,gene body | 6.51e-01 | 9.34e-01 | -4.02e+00 | 5.76e-05 | 5.76e-04 | -2.83e-01 |
| LUSC | cg07708516 | chr12:8662763 | CGI:chr12:8697456-8698807 | UTR,promoter,exon,gene body | 5.43e-01 | 8.35e-01 | -3.80e+00 | 1.47e-04 | 8.29e-04 | -2.92e-01 |
| LUSC | cg24229691 | chr12:8662984 | CGI:chr12:8697456-8698807 | promoter | 4.44e-01 | 6.18e-01 | -3.92e+00 | 8.72e-05 | 6.61e-04 | -1.74e-01 |
| LUSC | cg18574995 | chr12:8663038 | CGI:chr12:8697456-8698807 | promoter | 7.58e-01 | 9.53e-01 | -3.99e+00 | 6.62e-05 | 6.00e-04 | -1.95e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg24229691 | chr12:8662984 | CGI:chr12:8697456-8698807 | promoter | 4.96e-01 | 6.11e-01 | -8.31e+00 | 9.66e-17 | 4.02e-16 | -1.15e-01 |
| COAD | cg13679724 | chr12:8664037 | CGI:chr12:8697456-8698807 | promoter | 7.80e-01 | 9.17e-01 | -2.56e+00 | 1.04e-02 | 1.62e-02 | -1.37e-01 |
| BLCA | cg15815843 | chr12:8662712 | CGI:chr12:8697456-8698807 | UTR,promoter,exon,gene body | 6.86e-01 | 8.31e-01 | -2.07e+00 | 3.81e-02 | 4.15e-02 | -1.45e-01 |
| BLCA | cg07708516 | chr12:8662763 | CGI:chr12:8697456-8698807 | UTR,promoter,exon,gene body | 5.87e-01 | 7.15e-01 | -2.05e+00 | 4.02e-02 | 4.30e-02 | -1.28e-01 |
| LIHC | cg13679724 | chr12:8664037 | CGI:chr12:8697456-8698807 | promoter | 7.18e-01 | 9.17e-01 | -2.74e+00 | 6.12e-03 | 9.42e-03 | -1.99e-01 |
Top |
Exon skipping events with PSI in TCGA for MFAP5 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Landscape of exon skipping events across multiple cancer types. |
 |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for MFAP5 |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for MFAP5 |
| TFs related to MFAP5. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| UVM | AIRE | MFAP5 | 4.61e+00 | 9.82e-01 | 2.97e+00 | 4.99e-03 | Male-biased |
| UVM | ARID5B | MFAP5 | 4.76e+00 | 9.83e-01 | 3.24e+00 | 6.43e-03 | Male-biased |
| UVM | ATOH7 | MFAP5 | 5.74e+00 | 9.86e-01 | 4.49e+00 | 1.17e-02 | Male-biased |
| UVM | BATF | MFAP5 | 4.59e+00 | 9.81e-01 | 2.99e+00 | 5.47e-03 | Male-biased |
| UVM | BHLHE22 | MFAP5 | 5.56e+00 | 9.90e-01 | 4.04e+00 | 6.68e-03 | Male-biased |
| UVM | IRF7 | MFAP5 | 5.10e+00 | 9.87e-01 | 3.60e+00 | 6.83e-03 | Male-biased |
| UVM | MESP2 | MFAP5 | 5.53e+00 | 9.85e-01 | 4.28e+00 | 1.16e-02 | Male-biased |
| UVM | NEUROD1 | MFAP5 | 4.91e+00 | 9.85e-01 | 3.41e+00 | 6.70e-03 | Male-biased |
| UVM | NEUROG2 | MFAP5 | 5.77e+00 | 9.86e-01 | 4.53e+00 | 1.20e-02 | Male-biased |
| UVM | NKX6-3 | MFAP5 | 4.80e+00 | 9.84e-01 | 3.23e+00 | 5.83e-03 | Male-biased |
| UVM | OLIG1 | MFAP5 | 5.69e+00 | 9.89e-01 | 4.29e+00 | 8.70e-03 | Male-biased |
| UVM | OLIG3 | MFAP5 | 5.46e+00 | 9.87e-01 | 4.11e+00 | 9.46e-03 | Male-biased |
| UVM | TBP | MFAP5 | 4.45e+00 | 9.81e-01 | 2.42e+00 | 2.07e-03 | Male-biased |
| UVM | ZNF334 | MFAP5 | 4.53e+00 | 9.85e-01 | 1.12e+00 | 4.65e-05 | Male-biased |
| UVM | ZNF354B | MFAP5 | 4.68e+00 | 9.86e-01 | 2.58e+00 | 1.80e-03 | Male-biased |
| UVM | ZNF418 | MFAP5 | 4.41e+00 | 9.82e-01 | 6.02e-02 | 4.25e-06 | Male-biased |
| MFAP5 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for MFAP5 |
| RBPs related to ES in MFAP5. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| MFAP5 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
| ENSG00000197614 | PCAT19,hsa-mir-372,MFAP5 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000197614 | AL024507.2,hsa-mir-433,MFAP5 | Female-specific ceRNA | TCGA-KICH |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs116952980 | chr12:13825813:G:A | - | 0.260194674195868 | 0.00364217878731744 | READ | Female-baised eQTL |
| rs12298442 | chr12:5482653:A:G | - | 0.150127914864116 | 0.027684691926712 | PAAD | Female-baised eQTL |
| rs35934802 | chr12:5485556:G:A | - | 0.143658126881374 | 0.0389275636368802 | PAAD | Female-baised eQTL |
| rs35691544 | chr12:5485827:C:T | - | 0.143658126881374 | 0.0389275636368802 | PAAD | Female-baised eQTL |
| rs11062072 | chr12:234581:G:A | - | 0.149522255169949 | 0.00398257419109907 | LUSC | Female-baised eQTL |
| rs12830750 | chr12:233511:G:A | - | 0.14942900607019 | 0.00398257419109907 | LUSC | Female-baised eQTL |
| rs11062071 | chr12:234580:C:T | - | 0.14942900607019 | 0.00398257419109907 | LUSC | Female-baised eQTL |
| rs7969059 | chr12:236035:T:C | - | 0.14942900607019 | 0.00398257419109907 | LUSC | Female-baised eQTL |
| rs11062085 | chr12:236434:C:T | - | 0.14942900607019 | 0.00398257419109907 | LUSC | Female-baised eQTL |
| rs12580917 | chr12:237060:A:C | - | 0.14942900607019 | 0.00398257419109907 | LUSC | Female-baised eQTL |
| rs12366824 | chr12:251043:C:A | - | 0.149043620609292 | 0.00418270083705085 | LUSC | Female-baised eQTL |
| rs10848639 | chr12:254191:C:A | - | 0.149043620609292 | 0.00418270083705085 | LUSC | Female-baised eQTL |
| rs11613826 | chr12:242937:G:A | - | 0.149112682856483 | 0.00419586274002383 | LUSC | Female-baised eQTL |
| rs11062125 | chr12:244883:G:C | - | 0.149112682856483 | 0.00419586274002383 | LUSC | Female-baised eQTL |
| rs11062126 | chr12:244947:G:A | - | 0.149112682856483 | 0.00419586274002383 | LUSC | Female-baised eQTL |
| rs35311301 | chr12:245242:C:T | - | 0.149112682856483 | 0.00419586274002383 | LUSC | Female-baised eQTL |
| rs12826998 | chr12:248626:C:A | - | 0.149112682856483 | 0.00419586274002383 | LUSC | Female-baised eQTL |
| rs12825287 | chr12:249635:T:C | - | 0.149112682856483 | 0.00419586274002383 | LUSC | Female-baised eQTL |
| rs10848638 | chr12:254135:C:A | - | 0.149112682856483 | 0.00419586274002383 | LUSC | Female-baised eQTL |
| rs12579445 | chr12:237069:G:A | - | 0.149090984619228 | 0.00420440834036156 | LUSC | Female-baised eQTL |
| rs11062163 | chr12:255313:C:T | - | 0.128425835456055 | 0.0231848122880657 | LUSC | Female-baised eQTL |
| rs78082571 | chr12:4953984:A:G | - | 0.120501221126202 | 0.0453733963765424 | LUSC | Female-baised eQTL |
| rs4766316 | chr12:4954614:T:A | - | 0.120501221126202 | 0.0453733963765424 | LUSC | Female-baised eQTL |
| rs10840702 | chr12:17394822:G:T | - | 0.12328869517358 | 0.0304873511176535 | BLCA | Female-baised eQTL |
| rs12582159 | chr12:13378308:C:T | - | 0.0558432681838959 | 0.0226119610193742 | LUAD | Female-baised eQTL |
| rs10774279 | chr12:4879203:A:G | - | -0.0874148276374148 | 0.033019908011164 | LUAD | Female-baised eQTL |
| rs6489581 | chr12:4880461:C:A | - | -0.0873365394374253 | 0.0333736102958595 | LUAD | Female-baised eQTL |
| rs7138770 | chr12:14398948:C:T | - | 0.0712198294694384 | 0.0401336696278939 | LUAD | Female-baised eQTL |
| rs11054298 | chr12:11445413:T:C | - | 0.0747918326576011 | 0.0437701713145081 | COAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs79731558 | chr12:10301435:A:G | - | 0.229131347427175 | 0.0165791456140103 | READ | Male-baised eQTL |
| rs76934531 | chr12:10301436:T:C | - | 0.229131347427175 | 0.0165791456140103 | READ | Male-baised eQTL |
| rs34790670 | chr12:10298103:T:C | - | 0.217591495038153 | 0.0266445605198355 | READ | Male-baised eQTL |
| rs35868193 | chr12:10300131:T:G | - | 0.217591495038153 | 0.0266445605198355 | READ | Male-baised eQTL |
| rs79513651 | chr12:10301366:C:T | - | 0.217591495038153 | 0.0266445605198355 | READ | Male-baised eQTL |
| rs56410132 | chr12:15351856:C:T | - | 0.0931855532682955 | 0.00535724191306187 | HNSC | Male-baised eQTL |
| rs16910798 | chr12:15380636:T:C | - | 0.0933953528827187 | 0.00597375683808095 | HNSC | Male-baised eQTL |
| rs74720565 | chr12:15332212:G:A | - | 0.087768752253272 | 0.00794182027382687 | HNSC | Male-baised eQTL |
| rs12310930 | chr12:1329595:A:G | - | 0.189273422075582 | 0.00534875167166523 | THCA | Male-baised eQTL |
| rs2369282 | chr12:519557:T:C | - | -0.138651584741046 | 0.0108772618743835 | THCA | Male-baised eQTL |
| rs12823681 | chr12:18603076:G:A | - | 0.119303782205095 | 0.0158694485742165 | THCA | Male-baised eQTL |
| rs12828182 | chr12:18608949:G:A | - | 0.119303782205095 | 0.0158694485742165 | THCA | Male-baised eQTL |
| rs2277328 | chr12:18609516:A:C | - | 0.119303782205095 | 0.0158694485742165 | THCA | Male-baised eQTL |
| rs12809738 | chr12:18609179:G:A | - | 0.114141031667391 | 0.0219493808010993 | THCA | Male-baised eQTL |
| rs12826212 | chr12:18599514:G:A | - | 0.117577252189214 | 0.0247086639604287 | THCA | Male-baised eQTL |
| rs35801168 | chr12:18625377:G:A | - | 0.139876199930679 | 0.0340309597986626 | THCA | Male-baised eQTL |
| rs2532567 | chr12:4062144:G:C | - | 0.175096773023281 | 0.00967460334614148 | SARC | Male-baised eQTL |
| rs2540141 | chr12:4062416:C:T | - | 0.175096773023281 | 0.00967460334614148 | SARC | Male-baised eQTL |
| rs11063636 | chr12:5367396:A:G | - | -0.0379825594557529 | 0.00784851938151881 | LUSC | Male-baised eQTL |
| rs1124463 | chr12:5364266:G:A | - | -0.0381264552958178 | 0.00925611747095137 | LUSC | Male-baised eQTL |
| rs10774318 | chr12:5351541:T:G | - | -0.0380892436602816 | 0.00950814596354206 | LUSC | Male-baised eQTL |
| rs10735048 | chr12:5344245:C:T | - | -0.0379435309113241 | 0.00962012462222081 | LUSC | Male-baised eQTL |
| rs7132103 | chr12:5347810:C:T | - | -0.0375252465167101 | 0.0115485950567411 | LUSC | Male-baised eQTL |
| rs1124462 | chr12:5364139:C:A | - | -0.0359648540859225 | 0.0183635097633406 | LUSC | Male-baised eQTL |
| rs7307314 | chr12:5342965:T:C | - | -0.0363264502289292 | 0.0202039227843883 | LUSC | Male-baised eQTL |
| rs6489642 | chr12:5579034:G:A | - | 0.0373917127061516 | 0.0266937509041224 | LUSC | Male-baised eQTL |
| rs10774324 | chr12:5367231:T:C | - | -0.0345549811344015 | 0.0280713559716788 | LUSC | Male-baised eQTL |
| rs10774325 | chr12:5367739:C:T | - | -0.0334362664542864 | 0.03124852981699 | LUSC | Male-baised eQTL |
| rs7305796 | chr12:10140260:A:G | - | 0.0742821799944569 | 0.00360603300740469 | BLCA | Male-baised eQTL |
| rs11053630 | chr12:10141759:A:G | - | 0.0742821799944569 | 0.00360603300740469 | BLCA | Male-baised eQTL |
| rs12580875 | chr12:10148449:G:T | - | -0.07440546311619 | 0.00581565168990959 | BLCA | Male-baised eQTL |
| rs12316150 | chr12:10159692:A:T | - | 0.0701984430492749 | 0.0162626914470303 | BLCA | Male-baised eQTL |
| rs12309571 | chr12:10145410:T:C | - | 0.0684654550080158 | 0.0179577093491482 | BLCA | Male-baised eQTL |
| rs11053633 | chr12:10145674:A:T | - | 0.0684654550080158 | 0.0179577093491482 | BLCA | Male-baised eQTL |
| rs112901702 | chr12:10150979:T:A | - | 0.0684654550080158 | 0.0179577093491482 | BLCA | Male-baised eQTL |
| rs111532415 | chr12:10151277:G:A | - | 0.0684654550080158 | 0.0179577093491482 | BLCA | Male-baised eQTL |
| rs112843795 | chr12:10152217:G:A | - | 0.0684654550080158 | 0.0179577093491482 | BLCA | Male-baised eQTL |
| rs11053638 | chr12:10153242:G:C | - | 0.0684654550080158 | 0.0179577093491482 | BLCA | Male-baised eQTL |
| rs11053639 | chr12:10153459:A:G | - | 0.06840745025292 | 0.0180604635262902 | BLCA | Male-baised eQTL |
| rs11053640 | chr12:10153600:C:T | - | 0.06840745025292 | 0.0180604635262902 | BLCA | Male-baised eQTL |
| rs148379335 | chr12:10155229:T:C | - | 0.0687793134091135 | 0.0182071214566448 | BLCA | Male-baised eQTL |
| rs1050289 | chr12:10158567:C:T | - | 0.0687793134091135 | 0.0182071214566448 | BLCA | Male-baised eQTL |
| rs12305247 | chr12:10148755:A:G | - | 0.0683039859936851 | 0.0185941406201709 | BLCA | Male-baised eQTL |
| rs12300193 | chr12:10149574:C:T | - | 0.0683039859936851 | 0.0185941406201709 | BLCA | Male-baised eQTL |
| rs76675771 | chr12:10150220:T:C | - | 0.0683039859936851 | 0.0185941406201709 | BLCA | Male-baised eQTL |
| rs58564240 | chr12:10150963:T:C | - | 0.0683039859936851 | 0.0185941406201709 | BLCA | Male-baised eQTL |
| rs79161256 | chr12:10151903:C:T | - | 0.0683039859936851 | 0.0185941406201709 | BLCA | Male-baised eQTL |
| rs11053642 | chr12:10153692:T:C | - | 0.0682410917046868 | 0.0187153880266484 | BLCA | Male-baised eQTL |
| rs112673515 | chr12:10139720:C:T | - | 0.0682643376056307 | 0.0188160434262079 | BLCA | Male-baised eQTL |
| rs7977222 | chr12:10140919:T:C | - | 0.0682643376056307 | 0.0188160434262079 | BLCA | Male-baised eQTL |
| rs7969469 | chr12:4963344:G:A | - | 0.0610441423541578 | 0.0197314506099048 | BLCA | Male-baised eQTL |
| rs34291188 | chr12:10156982:A:G | - | 0.0669511199990317 | 0.0287697812687774 | BLCA | Male-baised eQTL |
| rs7970341 | chr12:18229439:G:A | - | -0.0407713852599456 | 0.029316411929261 | BLCA | Male-baised eQTL |
| rs7302045 | chr12:4971096:A:G | - | 0.0580017306003773 | 0.0297123777985856 | BLCA | Male-baised eQTL |
| rs10849182 | chr12:4965172:G:A | - | 0.0549979778595668 | 0.0381274079272545 | BLCA | Male-baised eQTL |
| rs7959096 | chr12:2340601:C:T | - | 0.0582618401806319 | 0.0392731506377457 | BLCA | Male-baised eQTL |
| rs6489364 | chr12:2340826:G:A | - | 0.0582618401806319 | 0.0392731506377457 | BLCA | Male-baised eQTL |
| rs7957028 | chr12:18229494:T:C | - | -0.0392136523671806 | 0.0473045646984223 | BLCA | Male-baised eQTL |
| rs11837266 | chr12:3237355:A:G | - | 0.0379715585085572 | 0.0150762467671027 | COAD | Male-baised eQTL |
| rs12302126 | chr12:8525050:T:C | - | 0.0625756487206003 | 0.0269028326672565 | COAD | Male-baised eQTL |
| rs12306856 | chr12:8525185:G:A | - | 0.0625756487206003 | 0.0269028326672565 | COAD | Male-baised eQTL |
| rs151143801 | chr12:17701092:G:A | - | 0.0537016012039272 | 0.0287782714360285 | COAD | Male-baised eQTL |
| rs113181367 | chr12:10178088:G:T | - | 0.0620593924925787 | 0.0317557225746332 | COAD | Male-baised eQTL |
| rs10770255 | chr12:17793770:A:T | - | 0.053091051496929 | 0.0342478535554544 | COAD | Male-baised eQTL |
| rs11043601 | chr12:17712151:C:T | - | 0.0521407449716767 | 0.0345228120067912 | COAD | Male-baised eQTL |
| rs7963488 | chr12:3238106:C:T | - | 0.033351100036007 | 0.0430863614266873 | COAD | Male-baised eQTL |
| rs35688880 | chr12:10171832:G:T | - | 0.0577717639977943 | 0.0478452376141582 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
 | Gene ID: ENSG00000197614 |
| CpG Site: cg18574995 | |
| Position to Gene: promoter | |
| Male Effect: -0.213057242260439 | |
| Female Effect: - | |
 | Gene ID: ENSG00000197614 |
| CpG Site: cg07708516 | |
| Position to Gene: gene,exon,promoter,UTR | |
| Male Effect: -0.487946981835077 | |
| Female Effect: - | |
 | Gene ID: ENSG00000197614 |
| CpG Site: cg18574995 | |
| Position to Gene: promoter | |
| Male Effect: -0.154706364247981 | |
| Female Effect: - |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg18574995 | chr12:8663038 | promoter | -0.213057242260439 | 1.2162425637582e-06 | -0.38450212212965984 | 2.859236751891601e-09 | LUAD |
| cg07708516 | chr12:8662763 | gene,exon,promoter,UTR | -0.487946981835077 | 2.00546444260712e-59 | -0.7918476621446909 | 4.6215693387401093e-64 | SKCM |
| cg18574995 | chr12:8663038 | promoter | -0.154706364247981 | 1.03511867504929e-11 | -0.4334348696536909 | 8.380421579663535e-15 | SKCM |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of MFAP5 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000197614 | MFAP5 | C4015368 | AORTIC ANEURYSM, FAMILIAL THORACIC 9 | 1 | CTD_human |
